How much funding has Zhaoke Ophthalmology raised?

Zhaoke Ophthalmology has raised $145.0M in total funding, most recently a Series B round.

Who are Zhaoke Ophthalmology's investors?

Zhaoke Ophthalmology's investors include GIC, Hillhouse Capital, TPG (Growth/Rise).

When was Zhaoke Ophthalmology founded?

Zhaoke Ophthalmology was founded in 2014.

Where is Zhaoke Ophthalmology headquartered?

Zhaoke Ophthalmology is headquartered in Hong Kong, Hong Kong.

What industry is Zhaoke Ophthalmology in?

Zhaoke Ophthalmology operates in Biotech, Healthcare.

How many employees does Zhaoke Ophthalmology have?

Zhaoke Ophthalmology has 51-200 employees.

Zhaoke Ophthalmology

IPO

Hong Kong, Hong Kong · Founded 2014 · $145.0M raised

Biotech

Healthcare

Headquarters: Hong Kong
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: zkoph.com
Total Funding: $145.0M
Last Round: $145.0M Series BOct 2020
Rounds: 1

About

Zhaoke Ophthalmology (HKEX: 6622) is a leading ophthalmic pharmaceutical company. Founded 2017. R&D, manufacturing, commercialization of ophthalmic therapies. 25 innovative and generic treatments. HQ Hong Kong, manufacturing Guangzhou.

Summary

Zhaoke Ophthalmology is a Biotech company based in Hong Kong, Hong Kong, founded in 2014. It has raised $145.0M in total across 1 round, most recently a $145.0M Series B round in Oct 2020. Investors include GIC, Hillhouse Capital and TPG (Growth/Rise).